Healthcare Global Enterprises

HCG delivered a steady Q3 FY26 with revenue of ₹633 croreCurrent reported value: revenue of ₹633 crore. No comparable prior figure is available in the source record. (+13.4Current reported value: 13.4. No comparable prior figure is available in the source record.% YoY) and adjusted EBITDA of ₹111 croreCurrent reported value: adjusted EBITDA of ₹111 crore. No comparable prior figure is available in the source record. (+20% YoY), with margins expanding 100 bps to 17.5%Current reported value: margins expanding 100 bps to 17.5%. No comparable prior figure is available in the source record.. Growth was driven by 8%Current 8%. Reported change: +8% YoY. patient volume growth and improving case mix, partially offset by a 20-25 day strike in Andhra Pradesh. Digital revenue grew 26%Current 26%. Reported change: +26% YoY. YoY with reduced paid media spend. Management reiterated 15%+ revenue growth guidance, with 10% volume and 5% ARPU contribution. Margin trajectory targets 23-24% in 3-4 years, supported by operating leverage and value initiatives. A rights issue was announced to strengthen the balance sheet. Risk: New greenfield hospitals (North Bangalore, Whitefield) may temporarily drag margins during ramp-up.